uric acid has been researched along with Diabetic Retinopathy in 43 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the association of uric acid (UA) and glucose in aqueous humor with diabetic macular edema (DME) in patients with Type 2 diabetes." | 8.12 | ELEVATED LEVEL OF URIC ACID, BUT NOT GLUCOSE, IN AQUEOUS HUMOR AS A RISK FACTOR FOR DIABETIC MACULAR EDEMA IN PATIENTS WITH TYPE 2 DIABETES. ( Chan, SO; He, BT; Qin, YJ; Wang, S; Yu, HH; Zhang, HY; Zhang, YL; Zhang, YQ, 2022) |
| "To investigate the role of serum uric acid and leukocyte counts and ratios as predictors of clinical outcomes of intravitreal bevacizumab in diabetic macular edema." | 8.12 | Association of White Blood Cell Counts, Leukocyte Ratios, and Serum Uric Acid with Clinical Outcome of Intravitreal Bevacizumab in Diabetic Macular Edema. ( Arabi, A; Karimi, S; Safi, S; Shahraki, T, 2022) |
| "To investigate the association between serum uric acid (SUA) levels and vision-threatening diabetic retinopathy (VTDR) in patients with type 2 diabetes." | 8.02 | Higher Serum Uric Acid Levels Are Associated With an Increased Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes Patients. ( Chan, Z; Chen, H; Gu, C; Hu, Y; Li, C; She, X; Shi, Y; Wang, Y; Zhao, S; Zheng, Z; Zhou, C, 2021) |
| "This study aims to investigate the relationship between serum uric acid (SUA) and the severity of diabetic nephropathy (DN) and diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM)." | 7.96 | Serum uric acid is independently associated with diabetic nephropathy but not diabetic retinopathy in patients with type 2 diabetes mellitus. ( Hu, AP; Li, DM; Su, S; Xia, Q; Yang, SM; Zhang, SH; Zhu, J; Zhu, XL, 2020) |
| "To analyze the associations of serum uric acid (SUA) level with diabetic microvascular complications, including diabetic retinopathy (DR) and diabetic nephropathy (DN), in patients with type 2 diabetes mellitus (DM)." | 7.96 | Associations of serum uric acid level with diabetic retinopathy and albuminuria in patients with type 2 diabetes mellitus. ( Chen, Q; Hou, L; Li, Q; Shi, Y; Wang, S; Zhao, M; Zhou, X, 2020) |
| "Uric acid has been proposed as an independent risk factor of diabetic retinopathy." | 7.88 | The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway. ( She, XP; Wang, YZ; Zheng, Z; Zhu, DD; Zou, C, 2018) |
| "We assessed the prospective association between baseline serum uric acid levels and consequent risk of developing diabetic retinopathy." | 7.85 | Serum uric acid levels are associated with increased risk of newly developed diabetic retinopathy among Japanese male patients with type 2 diabetes: A prospective cohort study (diabetes distress and care registry at Tenri [DDCRT 13]). ( Hayashino, Y; Ishii, H; Kuwata, H; Okamura, S; Tsujii, S, 2017) |
| "To explore the associations between urine uric acid excretion (UUAE) and diabetic retinopathy (DR)/lower limb atherosclerotic lesions in hospitalized Chinese patients with type 2 diabetes." | 7.81 | Decreased urine uric acid excretion is associated with diabetic retinopathy but not with lower limb atherosclerosis in hospitalized patients with type 2 diabetes. ( Bao, YQ; Chen, MY; Jia, WP; Li, LX; Li, TT; Lu, JX; Shuai, HP; Wang, JW; Xia, HF; Zhang, R, 2015) |
| "To explore the role of serum uric acid (SUA) concentration in diabetic retinopathy (DR) for patients with type 2 diabetes mellitus (T2DM)." | 7.80 | Serum uric acid concentration is associated with worsening in severity of diabetic retinopathy among type 2 diabetic patients in Taiwan--a 3-year prospective study. ( Chen, CH; Chen, YJ; Chung, MS; Kuo, HK; Lee, JJ; Liu, RT; Yang, IH, 2014) |
| " Lipid profiles, ACR, bilirubin, uric acid, creatine kinase, and hsCRP were not changed in DM patients with different diabetic duration or diabetic retinopathy." | 7.73 | Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. ( Chang, MH; Chen, TH; Chen, YJ; Hsu, HH; Huang, CY; Huang, EJ; Kuo, WW; Lee, SD; Lu, MC; Tzang, BS, 2006) |
| "A total of 518 individuals with type 2 diabetes were included." | 5.56 | Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes. ( Chen, D; Liu, Y; Sun, X; Zhao, X, 2020) |
| "Patients with type 2 diabetes mellitus (DM) may experience chronic microvascular complications such as diabetic retinopathy (DR) and diabetic nephropathy (DN) during their lifetime." | 5.43 | Association of Serum Uric Acid Concentration with Diabetic Retinopathy and Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus. ( Chen, SC; Hsiao, PJ; Hsu, WH; Lee, MY; Liang, CC; Lin, KD; Lin, PC; Shin, SJ, 2016) |
| "To determine the association of uric acid (UA) and glucose in aqueous humor with diabetic macular edema (DME) in patients with Type 2 diabetes." | 4.12 | ELEVATED LEVEL OF URIC ACID, BUT NOT GLUCOSE, IN AQUEOUS HUMOR AS A RISK FACTOR FOR DIABETIC MACULAR EDEMA IN PATIENTS WITH TYPE 2 DIABETES. ( Chan, SO; He, BT; Qin, YJ; Wang, S; Yu, HH; Zhang, HY; Zhang, YL; Zhang, YQ, 2022) |
| "To investigate the role of serum uric acid and leukocyte counts and ratios as predictors of clinical outcomes of intravitreal bevacizumab in diabetic macular edema." | 4.12 | Association of White Blood Cell Counts, Leukocyte Ratios, and Serum Uric Acid with Clinical Outcome of Intravitreal Bevacizumab in Diabetic Macular Edema. ( Arabi, A; Karimi, S; Safi, S; Shahraki, T, 2022) |
| "To investigate the association between serum uric acid (SUA) levels and vision-threatening diabetic retinopathy (VTDR) in patients with type 2 diabetes." | 4.02 | Higher Serum Uric Acid Levels Are Associated With an Increased Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes Patients. ( Chan, Z; Chen, H; Gu, C; Hu, Y; Li, C; She, X; Shi, Y; Wang, Y; Zhao, S; Zheng, Z; Zhou, C, 2021) |
| "This study aims to investigate the relationship between serum uric acid (SUA) and the severity of diabetic nephropathy (DN) and diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM)." | 3.96 | Serum uric acid is independently associated with diabetic nephropathy but not diabetic retinopathy in patients with type 2 diabetes mellitus. ( Hu, AP; Li, DM; Su, S; Xia, Q; Yang, SM; Zhang, SH; Zhu, J; Zhu, XL, 2020) |
| "To analyze the associations of serum uric acid (SUA) level with diabetic microvascular complications, including diabetic retinopathy (DR) and diabetic nephropathy (DN), in patients with type 2 diabetes mellitus (DM)." | 3.96 | Associations of serum uric acid level with diabetic retinopathy and albuminuria in patients with type 2 diabetes mellitus. ( Chen, Q; Hou, L; Li, Q; Shi, Y; Wang, S; Zhao, M; Zhou, X, 2020) |
| "Uric acid has been proposed as an independent risk factor of diabetic retinopathy." | 3.88 | The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway. ( She, XP; Wang, YZ; Zheng, Z; Zhu, DD; Zou, C, 2018) |
| "We assessed the prospective association between baseline serum uric acid levels and consequent risk of developing diabetic retinopathy." | 3.85 | Serum uric acid levels are associated with increased risk of newly developed diabetic retinopathy among Japanese male patients with type 2 diabetes: A prospective cohort study (diabetes distress and care registry at Tenri [DDCRT 13]). ( Hayashino, Y; Ishii, H; Kuwata, H; Okamura, S; Tsujii, S, 2017) |
| "To explore the associations between urine uric acid excretion (UUAE) and diabetic retinopathy (DR)/lower limb atherosclerotic lesions in hospitalized Chinese patients with type 2 diabetes." | 3.81 | Decreased urine uric acid excretion is associated with diabetic retinopathy but not with lower limb atherosclerosis in hospitalized patients with type 2 diabetes. ( Bao, YQ; Chen, MY; Jia, WP; Li, LX; Li, TT; Lu, JX; Shuai, HP; Wang, JW; Xia, HF; Zhang, R, 2015) |
| "To explore the role of serum uric acid (SUA) concentration in diabetic retinopathy (DR) for patients with type 2 diabetes mellitus (T2DM)." | 3.80 | Serum uric acid concentration is associated with worsening in severity of diabetic retinopathy among type 2 diabetic patients in Taiwan--a 3-year prospective study. ( Chen, CH; Chen, YJ; Chung, MS; Kuo, HK; Lee, JJ; Liu, RT; Yang, IH, 2014) |
| "Over a 20-year period, patients on dapagliflozin were projected to experience relative reductions in the incidence of myocardial infarction (MI), stroke, CV death, and all-cause death of 13." | 3.80 | Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes. ( Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J, 2014) |
| "Plasma levels for fasting glucose, glycosylated hemoglobin, ceruloplasmin and serum concentrations for fructosamine and uric acid were significantly increased in diabetic foot patients vs." | 3.74 | Diabetic foot patients with and without retinopathy and plasma oxidative stress. ( Coman, A; Găman, L; Greabu, M; Gruia, V; Mohora, M; Muscurel, C; Vîrgolici, B, 2007) |
| " Lipid profiles, ACR, bilirubin, uric acid, creatine kinase, and hsCRP were not changed in DM patients with different diabetic duration or diabetic retinopathy." | 3.73 | Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. ( Chang, MH; Chen, TH; Chen, YJ; Hsu, HH; Huang, CY; Huang, EJ; Kuo, WW; Lee, SD; Lu, MC; Tzang, BS, 2006) |
| " Patients within the lowest C-peptide quartile showed significantly higher duration of diabetes, prevalence of retinopathy and values of HDL-cholesterol, albumin excretion rate and HbA1c, while BMI, diastolic blood pressure, percentages of hypertension and metabolic syndrome, and values of triglycerides and uric acid were significantly higher in the highest C-peptide quartile." | 3.70 | Relationship of residual beta-cell function, metabolic control and chronic complications in type 2 diabetes mellitus. ( Bo, S; Cavallo-Perin, P; Gentile, L; Pagano, G; Repetti, E, 2000) |
| " In 2 cases a mild diabetes mellitus, in 7 cases uric acid level in serum was raised." | 3.65 | [Clinical-neurological and electromyographical studies of inpatients isolated with selective pigmentary retinopathy]. ( Eickhoff, W; Hellner, KA; Müller-Jensen, A, 1975) |
| "Patients with type 2 diabetes mellitus hospitalized over the period between January 2010 and September 2018 were retrospectively collected." | 1.72 | Using Machine Learning Techniques to Develop Risk Prediction Models for the Risk of Incident Diabetic Retinopathy Among Patients With Type 2 Diabetes Mellitus: A Cohort Study. ( Chen, W; Dong, M; Gao, Z; Li, P; Li, S; Li, X; Liu, X; Yu, H; Yu, Q; Zhang, M; Zhao, Y, 2022) |
| "299 patients with type 2 diabetes mellitus (T2DM) hospitalized in the Second Affiliated Hospital of Soochow University were enrolled." | 1.72 | Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus. ( Hu, J; Jiang, M; Wang, X; Yang, W; Zhang, HH; Zhang, S; Zhu, Y, 2022) |
| "A total of 518 individuals with type 2 diabetes were included." | 1.56 | Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes. ( Chen, D; Liu, Y; Sun, X; Zhao, X, 2020) |
| "Median time to recurrence was 64 months." | 1.56 | Predictive Factors for Kidney Stone Recurrence in Type 2 Diabetes Mellitus. ( Monga, M; Prasanchaimontri, P, 2020) |
| "Uric acid is a final breakdown product of purine catabolism in humans." | 1.46 | Correlation of retinal nerve fibre layer and macular thickness with serum uric acid among type 2 diabetes mellitus. ( Azreen-Redzal, A; Nyi-Nyi, N; Vinuthinee-Naidu, MN; Zunaina, E, 2017) |
| "Patients with type 2 diabetes mellitus (DM) may experience chronic microvascular complications such as diabetic retinopathy (DR) and diabetic nephropathy (DN) during their lifetime." | 1.43 | Association of Serum Uric Acid Concentration with Diabetic Retinopathy and Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus. ( Chen, SC; Hsiao, PJ; Hsu, WH; Lee, MY; Liang, CC; Lin, KD; Lin, PC; Shin, SJ, 2016) |
| "By analysing factors associated with diabetic nephropathy rather than microvascular disease in general, this study provides evidence that night-time diastolic BP and a relative increase in platelet count are associated with incipient diabetic nephropathy." | 1.38 | Factors associated with diabetic nephropathy in subjects with proliferative retinopathy. ( Buhagiar, G; Calleja, N; Fava, S; Magri, CJ; Vassallo, J, 2012) |
| "A total of 102 type 2 diabetes mellitus patients were divided into 2 groups: DR group (age, 60 +/- 6 years [mean +/- SD]; n = 31) and no diabetic retinopathy (NDR) group (59 +/- 5 years, n = 71)." | 1.36 | Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients. ( Anan, F; Eshima, N; Eto, T; Ito, Y; Masaki, T; Saikawa, T; Umeno, Y; Yoshimatsu, H, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (18.60) | 18.7374 |
| 1990's | 5 (11.63) | 18.2507 |
| 2000's | 3 (6.98) | 29.6817 |
| 2010's | 15 (34.88) | 24.3611 |
| 2020's | 12 (27.91) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, W | 1 |
| Shi, Y | 3 |
| Yang, J | 1 |
| Song, X | 1 |
| Zhang, Y | 1 |
| Zhang, W | 1 |
| Zhou, X | 2 |
| Qin, YJ | 1 |
| Zhang, YL | 1 |
| Zhang, YQ | 1 |
| He, BT | 1 |
| Wang, S | 2 |
| Yu, HH | 1 |
| Chan, SO | 1 |
| Zhang, HY | 1 |
| Karimi, S | 1 |
| Arabi, A | 1 |
| Shahraki, T | 1 |
| Safi, S | 1 |
| Zhao, Y | 1 |
| Li, X | 2 |
| Li, S | 1 |
| Dong, M | 1 |
| Yu, H | 1 |
| Zhang, M | 1 |
| Chen, W | 1 |
| Li, P | 1 |
| Yu, Q | 1 |
| Liu, X | 1 |
| Gao, Z | 1 |
| Wang, X | 1 |
| Yang, W | 1 |
| Zhu, Y | 1 |
| Zhang, S | 1 |
| Jiang, M | 1 |
| Hu, J | 1 |
| Zhang, HH | 1 |
| Pei, Y | 1 |
| Shu, Y | 1 |
| Deng, B | 1 |
| Liu, Y | 2 |
| Huang, JX | 1 |
| Liao, YF | 1 |
| Li, YM | 1 |
| Xia, Q | 1 |
| Zhang, SH | 1 |
| Yang, SM | 1 |
| Zhu, XL | 1 |
| Su, S | 1 |
| Hu, AP | 1 |
| Zhu, J | 1 |
| Li, DM | 1 |
| Prasanchaimontri, P | 1 |
| Monga, M | 1 |
| Lee, WL | 1 |
| Wang, PH | 1 |
| Chen, D | 1 |
| Sun, X | 1 |
| Zhao, X | 1 |
| Hou, L | 1 |
| Chen, Q | 1 |
| Li, Q | 1 |
| Zhao, M | 1 |
| Hu, Y | 2 |
| Chan, Z | 1 |
| Li, C | 2 |
| She, X | 1 |
| Gu, C | 1 |
| Wang, Y | 1 |
| Zhou, C | 1 |
| Zhao, S | 1 |
| Zheng, Z | 2 |
| Chen, H | 1 |
| Kuwata, H | 1 |
| Okamura, S | 1 |
| Hayashino, Y | 1 |
| Tsujii, S | 1 |
| Ishii, H | 1 |
| Vinuthinee-Naidu, MN | 1 |
| Zunaina, E | 1 |
| Azreen-Redzal, A | 1 |
| Nyi-Nyi, N | 1 |
| Cui, J | 1 |
| Ren, JP | 1 |
| Chen, DN | 1 |
| Xin, Z | 1 |
| Yuan, MX | 1 |
| Xu, J | 1 |
| You, QS | 1 |
| Yang, JK | 1 |
| Zhu, DD | 1 |
| Wang, YZ | 1 |
| Zou, C | 1 |
| She, XP | 1 |
| Ren, Y | 1 |
| Gao, L | 1 |
| Guo, X | 1 |
| Huo, X | 1 |
| Lu, J | 1 |
| Li, J | 2 |
| Ji, L | 1 |
| Yang, X | 1 |
| Thounaojam, MC | 1 |
| Montemari, A | 1 |
| Powell, FL | 1 |
| Malla, P | 1 |
| Gutsaeva, DR | 1 |
| Bachettoni, A | 1 |
| Ripandelli, G | 1 |
| Repossi, A | 1 |
| Tawfik, A | 1 |
| Martin, PM | 1 |
| Facchiano, F | 1 |
| Bartoli, M | 1 |
| Dziuba, J | 1 |
| Alperin, P | 1 |
| Racketa, J | 1 |
| Iloeje, U | 1 |
| Goswami, D | 1 |
| Hardy, E | 1 |
| Perlstein, I | 1 |
| Grossman, HL | 1 |
| Cohen, M | 1 |
| Lee, JJ | 1 |
| Yang, IH | 1 |
| Kuo, HK | 1 |
| Chung, MS | 1 |
| Chen, YJ | 2 |
| Chen, CH | 1 |
| Liu, RT | 1 |
| Li, LX | 1 |
| Lu, JX | 1 |
| Shuai, HP | 1 |
| Xia, HF | 1 |
| Zhang, R | 1 |
| Wang, JW | 1 |
| Chen, MY | 1 |
| Li, TT | 1 |
| Bao, YQ | 1 |
| Jia, WP | 1 |
| Liang, CC | 1 |
| Lin, PC | 1 |
| Lee, MY | 1 |
| Chen, SC | 1 |
| Shin, SJ | 1 |
| Hsiao, PJ | 1 |
| Lin, KD | 1 |
| Hsu, WH | 1 |
| Anan, F | 1 |
| Masaki, T | 1 |
| Ito, Y | 1 |
| Eto, T | 1 |
| Umeno, Y | 1 |
| Eshima, N | 1 |
| Saikawa, T | 1 |
| Yoshimatsu, H | 1 |
| Krizova, L | 1 |
| Kalousova, M | 1 |
| Kubena, A | 1 |
| Benakova, H | 1 |
| Zima, T | 1 |
| Kovarik, Z | 1 |
| Kalvoda, J | 1 |
| Kalvodova, B | 1 |
| Magri, CJ | 1 |
| Calleja, N | 1 |
| Buhagiar, G | 1 |
| Fava, S | 1 |
| Vassallo, J | 1 |
| Liu, Q | 1 |
| Cheng, R | 1 |
| Chen, Y | 1 |
| Lee, K | 1 |
| Yi, J | 1 |
| Liu, Z | 1 |
| Ma, JX | 1 |
| LAMAR, CP | 1 |
| Huang, EJ | 1 |
| Kuo, WW | 1 |
| Chen, TH | 1 |
| Chang, MH | 1 |
| Lu, MC | 1 |
| Tzang, BS | 1 |
| Hsu, HH | 1 |
| Huang, CY | 1 |
| Lee, SD | 1 |
| Mohora, M | 1 |
| Vîrgolici, B | 1 |
| Coman, A | 1 |
| Muscurel, C | 1 |
| Găman, L | 1 |
| Gruia, V | 1 |
| Greabu, M | 1 |
| Yanko, L | 1 |
| Goldbourt, U | 1 |
| Michaelson, IC | 1 |
| Shapiro, A | 1 |
| Yaari, S | 1 |
| Feldman, T | 1 |
| Weitzman, S | 1 |
| Biedner, B | 1 |
| Elbagir, MN | 1 |
| Eltom, MA | 1 |
| Mahadi, EO | 1 |
| Berne, C | 1 |
| Nishimura, M | 1 |
| Nakano, K | 1 |
| Ushiyama, M | 1 |
| Nanbu, A | 1 |
| Ohtsuka, K | 1 |
| Takahashi, H | 1 |
| Yoshimura, M | 1 |
| Bo, S | 1 |
| Cavallo-Perin, P | 1 |
| Gentile, L | 1 |
| Repetti, E | 1 |
| Pagano, G | 1 |
| Peng, Z | 1 |
| Wang, C | 1 |
| Gao, Q | 1 |
| Wang, Z | 1 |
| Zhang, G | 1 |
| Zhang, J | 1 |
| Peng, J | 1 |
| Jones, JJ | 1 |
| Watkins, PJ | 1 |
| Owyong, LY | 1 |
| Loh, PP | 1 |
| Kutty, MK | 1 |
| Jogie, B | 1 |
| Algan, B | 1 |
| Leyder, C | 1 |
| Marchal, H | 1 |
| Geoffroy, D | 1 |
| Marquis, A | 1 |
| Müller, G | 1 |
| Lantzsch, W | 1 |
| Schubert, J | 1 |
| Müller-Jensen, A | 1 |
| Eickhoff, W | 1 |
| Hellner, KA | 1 |
| Olukoga, AO | 1 |
| Erasmus, RT | 1 |
| Akinlade, KS | 1 |
| Okesina, AB | 1 |
| Alanamu, AA | 1 |
| Abu, EA | 1 |
| Hanna, AK | 1 |
| Roy, M | 1 |
| Zinman, B | 1 |
| McCulloch, JC | 1 |
| Mortimer, C | 1 |
| Falk, JA | 1 |
| Chipman, M | 1 |
| Gordon, AS | 1 |
| Marliss, EB | 1 |
| Darrelmann, O | 1 |
| Kreissig, I | 1 |
| Richard, G | 1 |
1 review available for uric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
CHELATION THERAPY OF OCCLUSIVE ARTERIOSCLEROSIS IN DIABETIC PATIENTS.
Topics: Aged; Arteriosclerosis; Blood Urea Nitrogen; Chelation Therapy; Dermatitis; Diabetes Mellitus; Diabe | 1964 |
42 other studies available for uric acid and Diabetic Retinopathy
| Article | Year |
|---|---|
Transthyretin and retinol-binding protein as discriminators of diabetic retinopathy in type 1 diabetes mellitus.
Topics: Apolipoproteins B; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Homocysteine; Humans; Prealbumin | 2022 |
ELEVATED LEVEL OF URIC ACID, BUT NOT GLUCOSE, IN AQUEOUS HUMOR AS A RISK FACTOR FOR DIABETIC MACULAR EDEMA IN PATIENTS WITH TYPE 2 DIABETES.
Topics: Aqueous Humor; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucose; Humans; Macular Edema; Risk | 2022 |
Association of White Blood Cell Counts, Leukocyte Ratios, and Serum Uric Acid with Clinical Outcome of Intravitreal Bevacizumab in Diabetic Macular Edema.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetes Mellitus; Diabetic | 2022 |
Using Machine Learning Techniques to Develop Risk Prediction Models for the Risk of Incident Diabetic Retinopathy Among Patients With Type 2 Diabetes Mellitus: A Cohort Study.
Topics: Cholesterol, LDL; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Machine L | 2022 |
Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus.
Topics: Carotid Intima-Media Thickness; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Ne | 2022 |
Association between brachial-ankle pulse wave velocity and microvascular complications in type 2 diabetes mellitus.
Topics: Ankle; Ankle Brachial Index; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diab | 2023 |
Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
Topics: Adult; Age of Onset; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetes Mel | 2019 |
Serum uric acid is independently associated with diabetic nephropathy but not diabetic retinopathy in patients with type 2 diabetes mellitus.
Topics: Aged; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopat | 2020 |
Predictive Factors for Kidney Stone Recurrence in Type 2 Diabetes Mellitus.
Topics: Aged; Asymptomatic Diseases; Body Mass Index; Calcium Oxalate; Causality; Cohort Studies; Comorbidit | 2020 |
Uric acid in diabetic nephropathy.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; | 2020 |
Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes.
Topics: Albumins; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Retrospective Studies; Uric Acid | 2020 |
Associations of serum uric acid level with diabetic retinopathy and albuminuria in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; F | 2020 |
Higher Serum Uric Acid Levels Are Associated With an Increased Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes Patients.
Topics: Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow | 2021 |
Serum uric acid levels are associated with increased risk of newly developed diabetic retinopathy among Japanese male patients with type 2 diabetes: A prospective cohort study (diabetes distress and care registry at Tenri [DDCRT 13]).
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Japan; M | 2017 |
Correlation of retinal nerve fibre layer and macular thickness with serum uric acid among type 2 diabetes mellitus.
Topics: Adult; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Follow-Up S | 2017 |
Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study.
Topics: Adult; Age Distribution; Aged; Blood Glucose; Blood Pressure; Body Mass Index; China; Cross-Sectiona | 2017 |
The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; | 2018 |
Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China.
Topics: Aged; Bilirubin; China; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; D | 2018 |
Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy.
Topics: Allopurinol; Animals; Benzbromarone; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; | 2019 |
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascul | 2014 |
Serum uric acid concentration is associated with worsening in severity of diabetic retinopathy among type 2 diabetic patients in Taiwan--a 3-year prospective study.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dise | 2014 |
Decreased urine uric acid excretion is associated with diabetic retinopathy but not with lower limb atherosclerosis in hospitalized patients with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Biomarkers; China; Comorbidity; Constriction, Pathologic; Cross-Sectional St | 2015 |
Association of Serum Uric Acid Concentration with Diabetic Retinopathy and Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus.
Topics: Aged; Albuminuria; Creatinine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Logi | 2016 |
Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients.
Topics: Adiposity; Aged; Anthropometry; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Di | 2010 |
Increased uric acid and glucose concentrations in vitreous and serum of patients with diabetic macular oedema.
Topics: Aged; Blood Glucose; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Female; Glycated He | 2011 |
Factors associated with diabetic nephropathy in subjects with proliferative retinopathy.
Topics: Aged; Albuminuria; Blood Pressure; Blood Sedimentation; C-Reactive Protein; Circadian Rhythm; Diabet | 2012 |
Nitrosative stress plays an important role in Wnt pathway activation in diabetic retinopathy.
Topics: Aldehydes; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme | 2013 |
Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy.
Topics: Aged; Albuminuria; Bilirubin; Biomarkers; Blood Glucose; C-Reactive Protein; Chromatography, High Pr | 2006 |
Diabetic foot patients with and without retinopathy and plasma oxidative stress.
Topics: Acute-Phase Proteins; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Foot; Di | 2007 |
Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Retinopathy; Humans; Israel; Male; Middle Ag | 1983 |
[Retinopathy and serum uric acid in diabetics].
Topics: Body Mass Index; Diabetes Mellitus; Diabetic Retinopathy; Humans; Male; Regression Analysis; Sex Fac | 1995 |
Pattern of long-term complications in Sudanese insulin-treated diabetic patients.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disord | 1995 |
Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Pressure; Diabetic Retinopathy; Fem | 1998 |
Relationship of residual beta-cell function, metabolic control and chronic complications in type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cohort Studies; Diabetes M | 2000 |
[Simultaneous determination of creatinine, pseudouridine and uric acid in serum and urine by high performance liquid chromatography].
Topics: Chromatography, High Pressure Liquid; Creatinine; Diabetic Nephropathies; Diabetic Retinopathy; Huma | 1998 |
Diabetes and its vascular complications in Malaysia.
Topics: Adult; Aged; Blood Glucose; Cerebrovascular Disorders; Cholesterol; Coronary Disease; Diabetes Melli | 1978 |
[Etiology of retinal venous thromboses].
Topics: Adult; Arteriosclerosis; Diabetic Retinopathy; Female; Humans; Hypertension; Retinal Vein; Thrombosi | 1976 |
[Glycoproteins in diabetes mellitus].
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Typ | 1975 |
[Clinical-neurological and electromyographical studies of inpatients isolated with selective pigmentary retinopathy].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diabetes Mellitus; Diabetic Retinopathy; Electroen | 1975 |
Plasma urate in diabetes: relationship to glycaemia, glucose disposal, microvascular complications and the variations following oral glucose.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; | 1991 |
An evaluation of factors associated with proliferative diabetic retinopathy.
Topics: Adult; Angina Pectoris; Blood Coagulation; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Neurop | 1985 |
[Bilateral retinal vein occlusions and general risk factors].
Topics: Aged; Constriction, Pathologic; Diabetic Retinopathy; Female; Heart Failure; Humans; Hypercholestero | 1985 |